Cite
HARVARD Citation
Shadman, M. et al. (n.d.). Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high‐risk myelodysplastic syndrome. American journal of hematology. 90 (6), pp. 483-486. [Online].